Cargando…
Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury
Chronic kidney disease (CKD), which is associated with high morbidity, remains a worldwide health concern, while effective therapies remain limited. Hydroxychloroquine (HCQ), which mainly targets toll-like receptor-7 (TLR-7) and TLR-9, is associated with a lower risk of incident CKD. Taking into acc...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079743/ https://www.ncbi.nlm.nih.gov/pubmed/33936063 http://dx.doi.org/10.3389/fimmu.2021.645100 |
_version_ | 1783685277582098432 |
---|---|
author | Zheng, Haofeng Zhang, Yannan He, Jiannan Yang, Zhe Zhang, Rui Li, Lei Luo, Zihuan Ye, Yongrong Sun, Qiquan |
author_facet | Zheng, Haofeng Zhang, Yannan He, Jiannan Yang, Zhe Zhang, Rui Li, Lei Luo, Zihuan Ye, Yongrong Sun, Qiquan |
author_sort | Zheng, Haofeng |
collection | PubMed |
description | Chronic kidney disease (CKD), which is associated with high morbidity, remains a worldwide health concern, while effective therapies remain limited. Hydroxychloroquine (HCQ), which mainly targets toll-like receptor-7 (TLR-7) and TLR-9, is associated with a lower risk of incident CKD. Taking into account that TLR-9 is involved in the development of renal fibrosis and serves as a potential therapy target for CKD, we investigated whether HCQ could attenuate CKD via TLR-9 signal pathway. The effects of HCQ on renal tubulointerstitial fibrosis were further explored using a mouse model of renal tubulointerstitial fibrosis after ischemia/reperfusion injury. Bone marrow-derived macrophages were isolated to explore the effects of HCQ in vitro. Judicious use of HCQ efficiently inhibited the activation of macrophages and MAPK signaling pathways, thereby attenuating renal fibrosis in vivo. In an in vitro model, results showed that HCQ promoted apoptosis of macrophages and inhibited activation of macrophages, especially M2 macrophages, in a dose-dependent manner. Because TLR-7 is not involved in the development of CKD post-injury, a TLR-9 knockout mouse was used to explore the mechanisms of HCQ. The effects of HCQ on renal fibrosis and macrophages decreased after depletion of TLR-9 in vivo and in vitro. Taken together, this study indicated that proper use of HCQ could be a new strategy for anti-fibrotic therapy and that TLR-9 could be a potential therapeutic target for CKD following acute kidney injury. |
format | Online Article Text |
id | pubmed-8079743 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80797432021-04-29 Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury Zheng, Haofeng Zhang, Yannan He, Jiannan Yang, Zhe Zhang, Rui Li, Lei Luo, Zihuan Ye, Yongrong Sun, Qiquan Front Immunol Immunology Chronic kidney disease (CKD), which is associated with high morbidity, remains a worldwide health concern, while effective therapies remain limited. Hydroxychloroquine (HCQ), which mainly targets toll-like receptor-7 (TLR-7) and TLR-9, is associated with a lower risk of incident CKD. Taking into account that TLR-9 is involved in the development of renal fibrosis and serves as a potential therapy target for CKD, we investigated whether HCQ could attenuate CKD via TLR-9 signal pathway. The effects of HCQ on renal tubulointerstitial fibrosis were further explored using a mouse model of renal tubulointerstitial fibrosis after ischemia/reperfusion injury. Bone marrow-derived macrophages were isolated to explore the effects of HCQ in vitro. Judicious use of HCQ efficiently inhibited the activation of macrophages and MAPK signaling pathways, thereby attenuating renal fibrosis in vivo. In an in vitro model, results showed that HCQ promoted apoptosis of macrophages and inhibited activation of macrophages, especially M2 macrophages, in a dose-dependent manner. Because TLR-7 is not involved in the development of CKD post-injury, a TLR-9 knockout mouse was used to explore the mechanisms of HCQ. The effects of HCQ on renal fibrosis and macrophages decreased after depletion of TLR-9 in vivo and in vitro. Taken together, this study indicated that proper use of HCQ could be a new strategy for anti-fibrotic therapy and that TLR-9 could be a potential therapeutic target for CKD following acute kidney injury. Frontiers Media S.A. 2021-04-14 /pmc/articles/PMC8079743/ /pubmed/33936063 http://dx.doi.org/10.3389/fimmu.2021.645100 Text en Copyright © 2021 Zheng, Zhang, He, Yang, Zhang, Li, Luo, Ye and Sun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Zheng, Haofeng Zhang, Yannan He, Jiannan Yang, Zhe Zhang, Rui Li, Lei Luo, Zihuan Ye, Yongrong Sun, Qiquan Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title | Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title_full | Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title_fullStr | Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title_full_unstemmed | Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title_short | Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury |
title_sort | hydroxychloroquine inhibits macrophage activation and attenuates renal fibrosis after ischemia-reperfusion injury |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079743/ https://www.ncbi.nlm.nih.gov/pubmed/33936063 http://dx.doi.org/10.3389/fimmu.2021.645100 |
work_keys_str_mv | AT zhenghaofeng hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT zhangyannan hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT hejiannan hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT yangzhe hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT zhangrui hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT lilei hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT luozihuan hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT yeyongrong hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury AT sunqiquan hydroxychloroquineinhibitsmacrophageactivationandattenuatesrenalfibrosisafterischemiareperfusioninjury |